C57BL/6JCya-Grik3em1flox/Cya
Common Name:
Grik3-flox
Product ID:
S-CKO-02752
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Grik3-flox
Strain ID
CKOCMP-14807-Grik3-B6J-VA
Gene Name
Product ID
S-CKO-02752
Gene Alias
9630027E11; GluK3; GluR7-3; Glur-7; Glur7
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
4
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Grik3em1flox/Cya mice (Catalog S-CKO-02752) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000030676
NCBI RefSeq
NM_001081097
Target Region
Exon 4
Size of Effective Region
~0.7 kb
Detailed Document
Overview of Gene Research
GRIK3, also known as Glutamate ionotropic receptor kainate type subunit 3, is a key excitatory neurotransmitter receptor in the mammalian brain. It belongs to the glutamate kainate receptor family and mainly participates in the neuroactive ligand receptor interaction pathway [3]. GRIK3 is involved in normal neurophysiologic processes such as synaptic potentiation, which is crucial for learning and memory [2].
GRIK3 has been implicated in multiple disease conditions. In non-small cell lung cancer (NSCLC), GRIK3 deficiency promotes cancer progression. It increases the expression of UBE2C and CDK1, activating the Wnt signaling pathway [1]. In gastric cancer (GC), higher GRIK3 expression is associated with poor survival outcomes, and it may be an independent prognostic factor [3]. In breast cancer, GRIK3 promotes epithelial-mesenchymal transition by regulating SPDEF/CDH1 signaling [4]. In colorectal cancer, the circRNA hsa_circ_0038646 promotes cell proliferation and migration via miR-331-3p/GRIK3, and circASXL1 acts oncogenically in CRC via sponging miR-1205 to upregulate GRIK3 [5,7]. Also, CHRNA3, GABRD, GRIK3, and GRIK5 were identified as a neurotransmitter receptor-related prognostic genes signature in colorectal cancer [9]. A girl with a 2.6-Mb microdeletion in 1p34.3 involving GRIK3 presented with severe developmental delay, suggesting GRIK3 haploinsufficiency may be responsible [2]. However, studies on GRIK3 (T928G) gene variants in schizophrenia patients and their relatives showed no significant differences in genotype distributions between patients and relatives, though the GG genotype frequency was higher in patients than in healthy controls [6]. And a family-based and case-control study found that the GRIK3 Ser310Ala polymorphism is not associated with alcohol dependence [8].
In conclusion, GRIK3 is essential for normal neurophysiological functions. Its dysregulation is associated with multiple cancers and developmental delay. Studies on GRIK3, including those potentially using gene knockout or conditional knockout models in the context of these diseases, help us understand its role in disease pathogenesis, providing potential directions for diagnosis, prognosis, and treatment development.
References:
1. Liu, Jun, Zhao, Zhu-Xiang, Li, Bin-Kai, Zhao, Zi-Wen. 2023. GRIK3 deficiency promotes non-small cell lung cancer progression by the regulation of the UBE2C/CDK1/Wnt signaling pathway. In American journal of cancer research, 13, 2066-2075. doi:. https://pubmed.ncbi.nlm.nih.gov/37293152/
2. Takenouchi, Toshiki, Hashida, Noriko, Torii, Chiharu, Takahashi, Takao, Kosaki, Kenjiro. 2013. 1p34.3 deletion involving GRIK3: Further clinical implication of GRIK family glutamate receptors in the pathogenesis of developmental delay. In American journal of medical genetics. Part A, 164A, 456-60. doi:10.1002/ajmg.a.36240. https://pubmed.ncbi.nlm.nih.gov/24449200/
3. Gong, Baocheng, Li, Yuan, Cheng, Zhenguo, Duan, Shijie, Liu, Funan. . GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 39, 1010428317704364. doi:10.1177/1010428317704364. https://pubmed.ncbi.nlm.nih.gov/28631555/
4. Xiao, Bin, Kuang, Zhenzhan, Zhang, Weiyun, Sun, Zhaohui, Li, Linhai. 2019. Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial-mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling. In Molecular carcinogenesis, 58, 1314-1323. doi:10.1002/mc.23014. https://pubmed.ncbi.nlm.nih.gov/30977227/
5. Du, Haipeng, He, Zhiguo, Feng, Fumei, Han, Enkun, Zhang, Jiansheng. 2020. Hsa_circ_0038646 promotes cell proliferation and migration in colorectal cancer via miR-331-3p/GRIK3. In Oncology letters, 20, 266-274. doi:10.3892/ol.2020.11547. https://pubmed.ncbi.nlm.nih.gov/32565953/
6. Kilic, Gamze, Ismail Kucukali, Cem, Orhan, Nurcan, Aydin, Makbule, Kara, Ihsan. 2009. Are GRIK3 (T928G) gene variants in schizophrenia patients different from those in their first-degree relatives? In Psychiatry research, 175, 43-6. doi:10.1016/j.psychres.2008.10.001. https://pubmed.ncbi.nlm.nih.gov/19995671/
7. Fang, Guojiu, Wu, Yibin, Zhang, Xueli. 2021. CircASXL1 knockdown represses the progression of colorectal cancer by downregulating GRIK3 expression by sponging miR-1205. In World journal of surgical oncology, 19, 176. doi:10.1186/s12957-021-02275-6. https://pubmed.ncbi.nlm.nih.gov/34127015/
8. Grzywacz, A, Małecka, I, Suchanecka, A, Bieńkowski, P, Samochowiec, J. 2012. Family-based and case-control study of glutamate receptor GRIK3 Ser310Ala polymorphism in alcohol dependence. In European addiction research, 19, 55-9. doi:10.1159/000341714. https://pubmed.ncbi.nlm.nih.gov/23006490/
9. Zhang, Linjie, Deng, Yizhang, Yang, Jingbang, Deng, Wuguo, Li, Liren. 2023. Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer. In Frontiers in cell and developmental biology, 11, 1202193. doi:10.3389/fcell.2023.1202193. https://pubmed.ncbi.nlm.nih.gov/38099288/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen